LivaNova (LIVN) Cash from Operations (2015 - 2026)
LivaNova (LIVN) reported Cash from Operations of 15216000.0 for Q1 2026, down 36.51% on a YoY basis from 23966000.0 in Q1 2025, and down 81.53% sequentially from 82397000.0 in Q4 2025.
LivaNova (LIVN) Cash from Operations (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Cash from Operations data on file, last reported at 15216000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 36.51% year-over-year to 15216000.0; the trailing twelve-month figure through Mar 2026 stood at 245590000.0 (up 24.65% YoY), and the FY2025 full-year result was 254340000.0, up 38.95% from the prior year.
- Cash from Operations eased to 15216000.0 in Q1 2026, from 82397000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 85057000.0 in Q3 2025 to a low of 17937000.0 in Q2 2023.
- A 5-year average of 35142882.35 and a median of 25823000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 139.96% in 2022 and soared 341.71% in 2024, its largest moves.
- Tracing LIVN's Cash from Operations over 5 years: stood at 18703000.0 in 2022, then jumped by 188.5% to 53958000.0 in 2023, then surged by 45.87% to 78707000.0 in 2024, then advanced by 4.69% to 82397000.0 in 2025, then plunged by 81.53% to 15216000.0 in 2026.
- Business Quant data shows LIVN's Cash from Operations at 15216000.0 in Q1 2026, 82397000.0 in Q4 2025, and 85057000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 15.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 82.40 Mn |
| Dec 31, 2025 | 82.40 Mn |
| Sep 30, 2025 | 85.06 Mn |
| Sep 30, 2025 | 85.06 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Mar 31, 2025 | 23.97 Mn |
| Mar 31, 2025 | 23.97 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 43.36 Mn |
| Jun 30, 2024 | 43.36 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 53.96 Mn |
| Dec 31, 2023 | 53.96 Mn |